References
- Axelsson R. On the serum concentrations and antipsychotic effects of thioridazine, thioridazine side-chain sulfoxide and thioridazine side-chain sulfone, in chronic psychotic patients. Current Therapeutic Research 1977; 21: 587–605
- Eap C. B., Souche A., Koeb L., Baumann P. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine. Therapeutic Drug Monitoring 1991; 13: 356–362
- Ganes D. A., Midha K. K. Sensitive and specific high-performance liquid chromatographic assay for the quantification of sulforidazine and two diastereomeric sulforidazine-5-sulfoxide metabolites in plasma. Journal of Chromatography 1987; 423: 227–237
- Green D. E., Serra M. T., Tucker J. D., Blum A. Metabolite patterns (profiles) of patients chronically dosed with thioridazine and mesoridazine. Phenothiazines and structurally related drugs: Basic and clinical studies, E. Usdin, H. Eckert, I. S. Forrest. Elsevier North-Holland, New York 1980; 169–172
- Hale P. W., Jr, Poklis A. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration. Journal of Analytical Toxicology 1985; 9: 197–201
- Jaworski T. J., Sardessai M. S., Aravagiri M., Lin G., Shi Y. Y., Hawes E. M., Hubbard Mc J. W., Kay G., Midha K. K. Synthesis of the N-oxides of phenothiazine antipsychotic agents. Journal of Pharmaceutical Sciences 1993, in press
- JØRgensen A. Metabolism and pharmacokinetics of antipsychotic drugs. Progress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud. Taylor & Francis, London 1986; vol. 9: 111–174
- Kinon G., Sakalis G., Traficante L. J., Aronson M., Bowers P., Gershon S. Mesoridazine in treatment-refractory schizophrenics. Current Therapeutic Research 1979; 25: 534–539
- Lin G., Midha K. K., Hawes E. M. Synthesis of the piperidinone metabolites of piperidine type phenothiazine antipsychotic drugs via ruthenium tetroxide oxidation. Journal of Heterocyclic Chemistry 1991; 28: 215–219
- Lin G., Hawes Mc E. M., Kay G., Midha K. K. The metabolism of piperidine-type phenothiazine antipsychotic agents. I. Sulforidazine in the rat. Xenobiotica 1992; 22: 303–317
- Lin G., Hawes Mc E. M., Kay G., Cooper S., Korchinski E. D., Midha K. K. The metabolism of piperidine-type phenothiazine antipsychotic agents. II. Sulforidazine in dog and human. Xenobiotica 1993; 23: 27–36
- Mohammad T., Midha K. K., Hawes E. M. Synthesis of deuterium labelled analogues of S-oxidative metabolites of thioridazine. Journal of Labelled Compounds and Radiopharmaceuticals 1989; 27: 181–188
- Papadopoulos A. S., Crammer J. L. Sulphoxide metabolites of thioridazine in man. Xenobiotica 1986; 16: 1097–1107
- Papadopoulos A. S., Crammer J. L., Cowan D. A. Phenolic metabolites of thioridazine in man. Xenobiotica 1985; 15: 309–316
- Poklis A., Wells C. E., Juenge E. C. Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides. Journal of Analytical Toxicology 1982; 6: 250–252
- Renz J., Bourquin J. P., Winkler H., Brueschweiler C., Schwarb G. Phenothiazines. French Patent 1964, 1,363,683 (Chemical Abstracts, 61, 14687d)
- Sakalis G., Traficante L. J., Gardos G., Gershon S. Treatment of drug-resistant schizophrenics with mesoridazine. Phenothiazines and Structurally Related Drugs: Basic and Clinical Studies, E. Usdin, H. Eckert, I. S. Forrest. Elsevier North-Holland, New York 1980; 207–214
- Watkins G. M., Whelpton R., Buckley D. G., Curry S. H. Chromatographic separation of thioridazine sulphoxide and N-oxide diastereoisomers: identification as metabolites in the rat. Journal of Pharmacy and Pharmacology 1986; 38: 506–509